Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
Clinical trial NCT05238792 · RECRUITING
Trial details
- NCT number
- NCT05238792
- Sponsor
- Children's National Research Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2028-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.